Testing a New Therapy for Trichotillomania (NCT00872742) | Clinical Trial Compass
CompletedPhase 2
Testing a New Therapy for Trichotillomania
United States85 participantsStarted 2009-03
Plain-language summary
This study will test the effectiveness of a new behavioral therapy for adults with trichotillomania (compulsive hair pulling).
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Current DSM-IV diagnosis of trichotillomania
* Massachusetts General Hospital Hair Scale score greater than 12
* Wechsler Test of Adult Reading score greater than 85
* Fluent in English
* Outpatient status
* Agreement to not alter the dosage of any psychotropic medication throughout the course of the study, or, if such a dosage change is required, understanding that the participant will continue to receive treatment, and data will continue to be collected on him or her
* Individuals who eat their hair after pulling will be eligible for participation only after they have received a physical exam from their primary care physician to determine whether there is any gastrointestinal blockage due to hair pulling, which would require more immediate clinical care.
Exclusion Criteria:
* Diagnosis of bipolar disorder, psychotic disorder, mental retardation, pervasive developmental disorder, or current substance dependence (with the exception of nicotine dependence)
* Current mood or anxiety disorder with an active suicide risk
* Currently receiving psychotherapy for trichotillomania or another psychiatric condition
* Initiation or change in the dosage of any psychotropic medication for up to 8 weeks preceding participation in the study
What they're measuring
1
Clinical Global Impressions-Improvement Scale
Timeframe: Measured after 6 weeks, 12 weeks, and 6 months